News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innovaro Facilitates the Licensing of Trojantec Ltd. Infectious Diseases Technology


6/11/2010 10:11:58 AM

TAMPA, Fla.--(BUSINESS WIRE)--Innovaro (NYSE Amex: INV), a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC (Verdant Ventures), and Trojantec Ltd (heretofore “Trojantec”), a London and Cyprus based biopharmaceutical company.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES